Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for Covid-19 vaccine
Drug firm Zydus Cadila on Sunday said it has received DCGI approval to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D. The company will now be initiating Phase III clinical trial in…